343856 Which one of the following is used as an immuno-suppressive agent in organ-transplant patients?

343858 Fill up blanks by selecting the correct option
i. ____ have been commercialized as blood cholesterol lowering agent
ii. ____ used as an immunosuppressive agent in organ transplant patients
iii.____ is a tissue plasminogen activator

343859 Streptokinase produced by the bacterium____ A____ and modified by genetic engineering is used as a____B____ for removing clots from the blood vessels of patients who have undergone ____C____.

343861 A good producer of citric acid is____

343856 Which one of the following is used as an immuno-suppressive agent in organ-transplant patients?

343858 Fill up blanks by selecting the correct option
i. ____ have been commercialized as blood cholesterol lowering agent
ii. ____ used as an immunosuppressive agent in organ transplant patients
iii.____ is a tissue plasminogen activator

343859 Streptokinase produced by the bacterium____ A____ and modified by genetic engineering is used as a____B____ for removing clots from the blood vessels of patients who have undergone ____C____.

343861 A good producer of citric acid is____

343856 Which one of the following is used as an immuno-suppressive agent in organ-transplant patients?

343858 Fill up blanks by selecting the correct option
i. ____ have been commercialized as blood cholesterol lowering agent
ii. ____ used as an immunosuppressive agent in organ transplant patients
iii.____ is a tissue plasminogen activator

343859 Streptokinase produced by the bacterium____ A____ and modified by genetic engineering is used as a____B____ for removing clots from the blood vessels of patients who have undergone ____C____.

343861 A good producer of citric acid is____

343856 Which one of the following is used as an immuno-suppressive agent in organ-transplant patients?

343858 Fill up blanks by selecting the correct option
i. ____ have been commercialized as blood cholesterol lowering agent
ii. ____ used as an immunosuppressive agent in organ transplant patients
iii.____ is a tissue plasminogen activator

343859 Streptokinase produced by the bacterium____ A____ and modified by genetic engineering is used as a____B____ for removing clots from the blood vessels of patients who have undergone ____C____.

343861 A good producer of citric acid is____